Skip to content
Riskpilot
← Back to search
Sign in
Get full access
THROMBOLOGIC ApS
APS
In liquidation
CVR 32299814
Ny Vestergade 7D, 1471
København K
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2009 · 16 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
THROMBOLOGIC ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
-1M
-2M
-3M
-3M
-3M
2012
EBITDA
DKK millions
0M
-1M
-2M
-3M
-4M
-3M
2012
Income statement
DKK thousands
Item
2012
Gross profit
-2.905
Staff expenses
-0
EBITDA
-3.032
Depreciation & amort.
-0
EBIT
-3.032
Net financials
-420
Profit before tax
-3.452
Tax
-660
Net profit
-2.792
Balance sheet
DKK thousands
Item
2012
Total assets
4.237
Equity
-1.332
Long-term debt
5.420
Short-term debt
149
Total debt
5.569
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-303227300.0%
This company
2012
2012
Equity ratio
-31.4%
This company
38.2%
Market median
-182% vs market
2012
2012
Return on equity
-279221200.0%
This company
18.4%
Market median
-1517506622% vs market
2012
2012
Net profit margin (of gross profit)
-279221200.0%
This company
2012
2012
Asset turnover (of gross profit)
-0.69×
This company
2012
2012
Debt / equity
4.18×
This company
0.62×
Market median
-574% vs market
2012
2012
Annual reports & filings
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
More on THROMBOLOGIC ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
